ADAR1 Capital Management, LLC

Position in CRNX — Crinetics Pharmaceuticals, Inc.

CIK 1940272 AUSTIN, TX

Position in CRNX

as of Mar 31, 2026 · filed May 18, 2026 Compact

Position Value

$41,380,501

+$26,979,421 QoQ

Shares Held

1,139,331

+268.3% QoQ

Ownership

1.08%

of shares outstanding

% of Portfolio

2.61%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Jun 2024

8 quarters on record

Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Healthcare · as of Mar 31, 2026

ADAR1 Capital Management, LLC holds $1,358,750,123 across 211 Biotechnology names. CRNX ranks #7 (3.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ABVX	Abivax S.A.	1,394,019	$155,224,015
2	PTGX	Protagonist Therapeutics, Inc	994,119	$104,780,142
3	ROIV	Roivant Sciences Ltd.	3,285,906	$91,019,596
4	IMVT	Immunovant, Inc.	2,679,010	$66,546,608
5	TERN	Terns Pharmaceuticals, Inc.	914,699	$48,222,931
6	CYTK	Cytokinetics Inc	632,556	$41,691,765
7	CRNX	Crinetics Pharmaceuticals, Inc. This page	1,139,331	$41,380,501
8	DNLI	Denali Therapeutics Inc.	1,871,455	$35,931,936

8 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$41,380,501	1,139,331	+268.3%	Shares	Sole	2026-05-18
2025-12-31	$14,401,080	309,368	+24.6%	Shares	Sole	2026-02-18
2025-09-30	$10,344,527	248,368	+367.5%	Shares	Sole	2025-11-14
2025-06-30	$1,527,875	53,125	0.0%	Shares	Sole	2025-08-14
2025-03-31	$1,781,812	53,125	0.0%	Shares	Sole	2025-05-15
2024-12-31	$2,716,281	53,125	-39.9%	Shares	Sole	2025-02-13
2024-09-30	$4,518,517	88,425	+18.1%	Shares	Sole	2024-11-14
2024-06-30	$3,352,531	74,850	—	Shares	Sole	2024-08-13
No filing history on record for this holder in this stock.